Evidence map›Paper›PMID 24304816›Full record

ArticleThe Journal of investigative dermatology2014

A fibronectin peptide redirects PDGF-BB/PDGFR complexes to macropinocytosis-like internalization and augments PDGF-BB survival signals.

Jia Zhu, Fubao Lin, Deborah A Brown, Richard A F Clark

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nanoparticles and nanofibers for topical drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2016
    Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jia ZhuDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA.
Fubao LinDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA.
Deborah A BrownDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA.
Richard A F ClarkDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA; Department of Dermatology, Stony Brook University, Stony Brook, New York, USA. Electronic address: richard.clark@stonybrook.edu.
Stony Brook University · US

Funding

Mechanistic studies of fibronectin peptide P12: a co-factor of PDGF-BBR21AR063445 · NIAMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI CLARK, RICHARD AUGUST · 2012 to 2013
$376k
NIAMS NIH HHS AR063445NIAMS NIH HHS R21 AR063445
6 · The paper itself

Abstract

Growth factor-binding domains identified in various extracellular matrix proteins have been shown to regulate growth factor activity in many ways. Recently, we identified a fibronectin peptide (P12) that can bind platelet-derived growth factor BB (PDGF-BB) and promote adult human dermal fibroblast (AHDF) survival under stress. In vivo experiments in a porcine burn injury model showed that P12 limited burn injury progression, suggesting an active role in tissue survival. In this report, we explored the molecular mechanism of this peptide in ADHF under nutrient deprivation. Our results showed that P12 acted like some cell-penetrating peptides in that it redirected ligand-bound PDGF receptor (PDGFR) from the clathrin-dependent endocytic pathway to a slower, macropinocytosis-like pathway. P12 slowed internalization and degradation of PDGF-BB, augmented its survival signals, and promoted cell survival after nutrient removal. Our findings demonstrate a mechanism for a potential therapeutic peptide that increases cell and tissue survival by acting as a cofactor to PDGF-BB.

Indexed as

PinocytosisBecaplerminCell SurvivalClathrinDisease ProgressionEndocytosisFibroblastsFibronectinsHumansLigandsMCF-7 CellsModels, AnimalPeptidesPhosphorylationProto-Oncogene Proteins c-sisReceptors, Platelet-Derived Growth FactorBecaplerminClathrinFibronectinsLigandsPeptidesProto-Oncogene Proteins c-sisReceptors, Platelet-Derived Growth Factor

Identifiers

PMID24304816
PMCPMC3961502
OpenAlexW2030430216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.